These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26280926)

  • 1. Analytical and statistical comparability of generic enoxaparins from the US market with the originator product.
    Mourier PA; Agut C; Souaifi-Amara H; Herman F; Viskov C
    J Pharm Biomed Anal; 2015 Nov; 115():431-42. PubMed ID: 26280926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of generic enoxaparins marketed in the United States by employing NMR and multivariate analysis.
    Guerrini M; Rudd TR; Mauri L; Macchi E; Fareed J; Yates EA; Naggi A; Torri G
    Anal Chem; 2015 Aug; 87(16):8275-83. PubMed ID: 26189325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of sulfation degree of heparin and low molecular weight heparins by capillary electrophoresis].
    Shen Y; Kang J
    Se Pu; 2020 Oct; 38(10):1238-1242. PubMed ID: 34213122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical comparison of a US generic enoxaparin with the originator product: The focus on comparative assessment of antithrombin-binding components.
    Mourier PAJ; Herman F; Sizun P; Viskov C
    J Pharm Biomed Anal; 2016 Sep; 129():542-550. PubMed ID: 27497655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Immunostimulatory Potential of Branded and US-Generic Enoxaparins in an In Vitro Human Immune System Model.
    Luna E; Agrawal P; Mehta R; Vernhes C; Viskov C; Amiral J; Warren WL; Drake DR
    Clin Appl Thromb Hemost; 2015 Apr; 21(3):211-22. PubMed ID: 25525049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Authentication of animal origin of heparin and low molecular weight heparin including ovine, porcine and bovine species using 1D NMR spectroscopy and chemometric tools.
    Monakhova YB; Diehl BWK; Fareed J
    J Pharm Biomed Anal; 2018 Feb; 149():114-119. PubMed ID: 29112899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of contaminants in recalled unfractionated heparin and low-molecular-weight heparin.
    Viskov C; Bouley E; Hubert P; Martinez C; Herman F; Jeske W; Hoppensteadt D; Walenga JM; Fareed J
    Clin Appl Thromb Hemost; 2009; 15(4):395-401. PubMed ID: 19617248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Top-down and bottom-up analysis of commercial enoxaparins.
    Liu X; St Ange K; Lin L; Zhang F; Chi L; Linhardt RJ
    J Chromatogr A; 2017 Jan; 1480():32-40. PubMed ID: 28011077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generic low-molecular-weight heparins: some practical considerations.
    Fareed J; Leong WL; Hoppensteadt DA; Jeske WP; Walenga J; Wahi R; Bick RL
    Semin Thromb Hemost; 2004 Dec; 30(6):703-13. PubMed ID: 15630677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin III-Binding Site Analysis of Low-Molecular-Weight Heparin Fractions.
    Chen Y; Zhao J; Yu Y; Liu X; Lin L; Zhang F; Linhardt RJ
    J Pharm Sci; 2018 May; 107(5):1290-1295. PubMed ID: 29339133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The United States Food and Drugs Administration approves a generic enoxaparin.
    Ofosu FA
    Clin Appl Thromb Hemost; 2011 Feb; 17(1):5-8. PubMed ID: 21159709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Product individuality of commercially available low-molecular-weight heparins and their generic versions: therapeutic implications.
    Maddineni J; Walenga JM; Jeske WP; Hoppensteadt DA; Fareed J; Wahi R; Bick RL
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):267-76. PubMed ID: 16959680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboelastographic evaluation of blood coagulation in the presence of branded and generic enoxaparins.
    Walenga JM; Jeske WP; Escalante V; Hoppensteadt D; Fareed J; Bakhos M
    Int Angiol; 2012 Dec; 31(6):517-25. PubMed ID: 23222929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and pharmacological profile of generic enoxaparins used in Brazil.
    Lima MA; de Farias EH; Gray A; Sadeghi N; Gesteira TF; Cavalheiro RP; Hoppensteadt D; Fareed J; Sassaki GL; Nader HB
    Clin Appl Thromb Hemost; 2012 Jul; 18(4):379-86. PubMed ID: 22395574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative studies on branded enoxaparin and a US generic version of enoxaparin.
    Walenga JM; Jeske WP; Hoppensteadt D; Cunanan J; Khan H; Escalante V; Fareed J; Bakhos M
    Clin Appl Thromb Hemost; 2013 Jun; 19(3):261-7. PubMed ID: 23091283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional analyses of biosimilar enoxaparins available in Brazil.
    Oliveira SN; Santos GR; Glauser BF; Capillé NV; Queiroz IN; Pereira MS; Pomin VH; Mourão PA
    Thromb Haemost; 2015 Jan; 113(1):53-65. PubMed ID: 25252953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple capillary electrophoresis method for the rapid separation and determination of intact low molecular weight and unfractionated heparins.
    Patel RP; Narkowicz C; Hutchinson JP; Hilder EF; Jacobson GA
    J Pharm Biomed Anal; 2008 Jan; 46(1):30-5. PubMed ID: 18024047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and haemostatic effects of generic versions of enoxaparin available for clinical use in Brazil: similarity to the original drug.
    Glauser BF; Vairo BC; Oliveira SN; Cinelli LP; Pereira MS; Mourão PA
    Thromb Haemost; 2012 Feb; 107(2):302-14. PubMed ID: 22234635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
    Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
    Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic analysis of enoxaparins from different sources with online one- and two-dimensional chromatography.
    Ouyang Y; Zhu M; Wang X; Yi L; Fareed J; Linhardt RJ; Zhang Z
    Analyst; 2019 Jun; 144(12):3746-3755. PubMed ID: 31016304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.